MYB and neoplasm: In c-MYB + lines, the reduction in MYBBP1A levels causes an increase in the number of Cancer Stem Cells (CSCs) the capacity of tumor-formation and the expression of genes related to the regulation of the pluripotency of tumor stem cells and the epithelium–mesenchyme transition [51].